Shaoyi Sun

USPTO Granted Patents = 49 (Patent Applications = 15)

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 24 (Patent Applications = 28)

Average Co-Inventor Count = 11.0

ph-index = 13

Forward Citations = 441(Granted Patents)

Location History:

Coquitlam, CA (US) (2011)
Vancouver, CA (2008 - 2013)
Burnaby, CA (2015 - 2021)
Coquitlam, CA (2009 - 2024)

Company Filing History:

46 out of 109

Xenon Pharmaceuticals Inc.

where one patent can have more than one assignee

Years Active: 2008-2024

Loading Chart...

49 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12054486 - Pyridine derivatives and their use as sodium channel activators (2024-08-06),

2. 11639351 - Heteroaryl-substituted sulfonamide compounds and their use as therapeutic agents (2023-05-02),

3. 11149002 - Therapeutic compounds and methods of use thereof (2021-10-19),

4. 10981905 - Heteroaryl-substituted sulfonamide compounds and their use as therapeutic agents (2021-04-20),

5. 10526285 - Therapeutic compounds and methods of use thereof (2020-01-07),

6. 10179767 - Substituted benzamides and methods of use thereof (2019-01-15),

7. 10125098 - Therapeutic compounds and methods of use thereof (2018-11-13),

8. 10005724 - Therapeutic compounds and methods of use thereof (2018-06-26),

9. 9771376 - N-substituted benzamides and methods of use thereof (2017-09-26),

10. 9694002 - Substituted benzamides and methods of use thereof (2017-07-04),

11. 9630929 - Benzenesulfonamide compounds and their use as therapeutic agents (2017-04-25),

12. 9550775 - Substituted triazolopyridines and methods of use thereof (2017-01-24),

13. 9546164 - Substituted benzamides and methods of use thereof (2017-01-17),

14. 9493429 - Substituted benzoxazoles and methods of use thereof (2016-11-15),

15. 9487535 - Asymmetric syntheses for spiro-oxindole compounds useful as therapeutic agents (2016-11-08),

Title: The Innovative Mind of Shaoyi Sun: A Pioneer in Sodium Channel Research

Introduction: Shaoyi Sun, based in Coquitlam, Canada, is a renowned inventor and researcher with an impressive portfolio of 49 patents. His work predominantly focuses on pharmaceutical innovations, particularly pertaining to sodium channel activators that contribute to the treatment of significant medical conditions such as epilepsy.

Latest Patents: Among his latest contributions to the field, Sun has developed compounds that include pyridine derivatives designed to act as sodium channel activators. This inventive approach aims to provide therapeutic agents that target diseases associated with voltage-gated sodium channels. His noteworthy inventions also incorporate benzenesulfonamide compounds in various forms, including stereoisomers, enantiomers, and tautomers, for treating epilepsy and related seizure disorders.

Career Highlights: Throughout his career, Shaoyi Sun has made significant strides in pharmaceutical sciences as part of prominent companies such as Xenon Pharmaceuticals Inc. and Genentech, Inc. His innovative research and commitment to advancing medical therapies have solidified his reputation in the industry.

Collaborations: Sun has collaborated with esteemed colleagues, including Sultan Chowdhury and Shifeng Liu, to further develop and promote his groundbreaking research initiatives. These partnerships have played a crucial role in enhancing the scope and impact of his inventions.

Conclusion: With 49 patents to his name, Shaoyi Sun continues to be a pivotal figure in the field of medicinal chemistry. His innovations not only represent significant scientific advancements but also hold the potential to transform the lives of individuals suffering from severe health conditions. As he moves forward, the medical community eagerly anticipates the further developments that will emerge from his inspired work.

This text is generated by artificial intelligence and may not be accurate.